HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.

AbstractOBJECTIVE:
To determine the correlation of cell adhesion molecules (osteopontin-c, E-cadherin and β-catenin) with clinicopathological characteristics in breast cancer.
METHODS:
Immunostaining of osteopontin-c, E-cadherin and β-catenin were conducted in 170 samples of breast cancer and 30 samples of adjacent normal breast tissues. The correlation of osteopontin-c, E-cadherin and β-catenin expression level with clinicopathological characteristics was evaluated by Pearson's chi-square and Wilcoxon rank-sum test. Univariate and multivariate Cox hazard regression model was used to assess the prognostic values of osteopontin-c, E-cadherin and β-catenin in clinical outcome of breast cancer.
RESULTS:
A higher level of osteopontin-c whereas lower levels of E-cadherin and β-catenin were observed in breast cancer as compared with the normal breast tissues. The expression of osteopontin-c was negatively associated with the expression of E-cadherin and β-catenin. The expression of osteopontin-c correlated with lymph node metastasis, and advanced TNM stage and histologic grade. The expression of E-cadherin correlated with low histologic grade; and β-catenin with low TNM stage and histological grade. Moreover, high osteopontin-c level correlated with tumor recurrence or metastasis as well as triple negative subtype. The expression of osteopontin-c was an independent prognostic factor for both disease-free and overall survival of breast cancer patients.
CONCLUSION:
The data suggest that the expression of osteopontin-c could serve as a prognostic factor of breast cancer.
AuthorsHui Pang, Hailing Lu, Hongtao Song, Qingwei Meng, Yanbin Zhao, Na Liu, Fei Lan, Ying Liu, Suhong Yan, Xiaoqun Dong, Li Cai
JournalCancer epidemiology (Cancer Epidemiol) Vol. 37 Issue 6 Pg. 985-92 (Dec 2013) ISSN: 1877-783X [Electronic] Netherlands
PMID24012693 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • CTNNB1 protein, human
  • Cadherins
  • beta Catenin
  • Osteopontin
Topics
  • Adolescent
  • Adult
  • Biomarkers, Tumor (metabolism)
  • Breast (metabolism, pathology)
  • Breast Neoplasms (metabolism, mortality, pathology)
  • Cadherins (metabolism)
  • Carcinoma, Ductal, Breast (metabolism, mortality, pathology)
  • Carcinoma, Lobular (metabolism, mortality, pathology)
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local (metabolism, mortality, pathology)
  • Neoplasm Staging
  • Osteopontin (metabolism)
  • Prognosis
  • Survival Rate
  • Young Adult
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: